Cannabics Pharmaceuticals (CNBX.OTC) announced that its recent tests have shown that the cannabinoids CBC (cannabichromene) and CBD (cannabigerol) both exhibit anti-tumour properties when tested on human gastrointestinal cancer cells….
Latest News
Prospera Energy (PEI.V) goes to borrowers again as boe/d drops 20%
Argo Living Soils (ARGO.C) creates carbon rich biochar.. could that be turned into graphene?
Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up 400% in a month
3 lists of Buzzfeedy reasons why Skyharbour Resources (SYH.V) goes against the grain
Onco Innovations (ONCO.C): What if we could stop cancer coming back?
Vancouver Resource Investment Conference 2025 comes to a close: Here’s what we saw